Epigenetic reprogramming and hypothalamic changes in metabolic syndrome

FHS
July 30, 2024
6:11 pm

Metabolic syndrome (MetS) is a multifaceted disorder that impacts approximately 20–25% of the global population.

Baxter signs over kidney care arm to investment firm in $3.5bn deal – Pharmaceutical Technology

The agreement comes following a March 2024 announcement in which the company detailed that it was looking to either spin out or sell off its

August 13, 2024

Freenome raises $254M to study cancer screening tests

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Freenome has raised $254 million

February 16, 2024

Supreme Court to weigh whether Covid misinformation is protected speech

WASHINGTON — As social media sites were flooded with misleading posts about vaccine safety, mask effectiveness, Covid-19’s origins and federal shutdowns, Biden officials urged platforms

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.